Senior director, country manager, switzerland
BaselRevolution Medicines
...RAS(ON) G12 C‑selective inhibitor; zoldonrasib (RMC‑XXXX), a RAS(ON) G12 D‑selective inhibitor; and RMC‑XXXX, a RAS(ON) G12 V‑selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients [...]
Kategorie Handel